RECENT NEWS

Linkam, a market leader in temperature and environmental-controlled microscopy, presented its range of cryo workflow solutions and sample characterisation tools at Microscopy and Microanalysis (M&M) 2022.

Bio-Rad Laboratories has extended its range of StarBright dyes to include StarBright Violet 760, StarBright UltraViolet 575 and StarBright UltraViolet 605 dyes, offering improved brightness with narrow excitation and emission profiles.

‘Point of Care: Innovations’ is a free-to-attend meeting for NHS staff being held in Bristol at The Bristol – Harbourside (Doyle Collection) hotel on 20 September. Click on this item to access the confirmed programme.

Point-of-care testing has found application across the breadth of healthcare, a recent prime example being the role of viscoelastic POC testing in post-partum bleeding management in obstetrics.

Data from C2N Diagnostics shows that a blood test combining the Aβ42/40 ratio, a component of C2N’s PrecivityAD blood test, offers accuracy comparable to amyloid PET imaging and invasive CSF tests in identifying Alzheimer’s brain pathology.

A new College of American Pathologists (CAP) evidence-based guideline is among the first to address testing based less on the cancer type or tumour origin and more on the methodology and status of a biomarker.

The American Gastroenterological Association recently published a best practice advice article stating that the TissueCypher Barrett’s oesophagus test may be beneficial for risk-stratification in cases of non-dysplastic Barrett’s oesophagus (BE).

Thermo Fisher Scientific enables clinical research, toxicology and anti-doping laboratories performing dried spot sampling and analysis to utilise a new automated sample preparation and ultra-high-performance liquid chromatography (UHPLC) system.

San Paolo Hospital in Savona, Italy, has upgraded its Corelab-related analytical equipment. In collaboration with Beckman Coulter, the San Paolo diagnostic laboratory has installed Beckman Coulter's DxA 5000 Laboratory Automation System.

It’s competition time at INTEGRA Biosciences, and the company is giving away the world’s most affordable and portable 96-channel pipette.

Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, has announced a new addition to its range of products for scientists developing immunoassays for the serology and diagnostics markets.

In this Opinion feature, Sheri Scott, senior lecturer and course leader for the IBMS-accredited BSc Applied Biomedical Science at Nottingham Trent University, gives her views.

Quanterix has announced the validation of a laboratory developed test (LDT) to quantitatively measure phospho-Tau 181 (pTau-181) in plasma as an aid in diagnostic evaluation of Alzheimer’s disease (AD).

The IBMS and The Royal College of Pathologists (RCPath) have collaborated to provide the profession with guidance around the emerging issue with the supply of wax for processing and embedding histopathology samples.

Digital pathology solution provider OptraSCAN has announced that it has received CE-IVDR marking for the OS-Ultra scanners, its high-performance product line of brightfield scanners, including pay-per-scan based OPEX models.

A team of scientists working at North East Innovation Lab has secured a share of £218,000 funding from Cancer Research UK for a consortium project to develop a new diagnostic for the early detection of pancreatic cancer.

PCR Biosystems has launched Air-Dryable Probe 1-Step Mix, described as a versatile all-in-one, air-dryable 4x RT-qPCR reagent mix for ultra-sensitive detection of RNA and DNA sequences.

Roche Diagnostics UK & Ireland has welcomed NICE’s new guidance recommending routine use of placental growth factor (PlGF)-based testing in the NHS in England and Wales to help diagnose suspected pre-eclampsia.

The King’s Fund is hosting a one-day conference in London on 16 November, looking at the future role of diagnostics in the NHS.

Teesside University has announced plans for a new £35m central science and medical building which will provide cutting-edge new laboratories for the sciences and clinical subjects.